AHF Applauds Congressional Demand that Drug Companies Follow Laws on 3...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 26, 2024

Colgate Announces 1st Quarter 2024 Results • Vantage unveils significant impact of donation on UNHCR's ongoing refugee support in Australia • Body & Brain Yoga Tai Chi Announces a New Qigong Basics Course at Nationwide Locations • Galvanize Real Estate Acquires First Asset in Pioneering Profitable Decarbonization Strategy • Rooter Hero Plumbing & Air's employees host clothing drive for Hope the Mission shelters • Pearson 2024 Q1 Trading Update (Unaudited) • J&T Express Releases Inaugural Environmental, Social and Governance Report: Pushes for Green Operations across the Entire Ch • Global Conservation Leaders Unite in Saudi Arabia's Hima Protected Areas Forum, Setting Bold Agenda for Sustainable Future • COP28 President urges governments to 'think bigger, act bolder' on national climate plans that are aligned with the UAE Consensu • Delta Recognized with the ENERGY STAR® Partner of the Year - Sustained Excellence Award for the 7th Year in a Row • VNET Publishes 2023 Environment, Social and Governance Report • Freeport-McMoRan Publishes 2023 Annual Report on Sustainability • New Research from Material and NewtonX Reveals Shifts in Digital Ad Spending and Social Media Strategies • AACN’s New Web Resource Focuses on Preparing Nurses with Essential Well-Being and Leadership Competencies • New Report: Employers Play Critical Role in Curbing Today's Youth Mental Health Crisis • AHF Praises Colombia for Putting Lives Before Pharma Greed • BUILDING HOPE ANNOUNCES THIRD ANNUAL IMPACT GRANT WINNERS • Sanborn’s Broadband Navigator™ is Available for Streamlined Purchase on NASPO • Conservation International Honors Jeff Bezos and Lauren Sánchez with its Global Visionary Award • PharMerica Donates 719,287 Prescriptions to Underserved Patients in 2023

AHF Applauds Congressional Demand that Drug Companies Follow Laws on 340B Drug Program

WASHINGTON , September 15 /Businesswire/ - The idea that drug companies like AstraZeneca, Eli Lilly, Merck, Novartis and Sanofi can unilaterally regulate the 340B Drug Discount Program themselves is ridiculous and has been rejected by 243 members of Congress. Drug companies are NOT above the law.